CY1124177T1 - Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τ - Google Patents
Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τInfo
- Publication number
- CY1124177T1 CY1124177T1 CY20211100455T CY211100455T CY1124177T1 CY 1124177 T1 CY1124177 T1 CY 1124177T1 CY 20211100455 T CY20211100455 T CY 20211100455T CY 211100455 T CY211100455 T CY 211100455T CY 1124177 T1 CY1124177 T1 CY 1124177T1
- Authority
- CY
- Cyprus
- Prior art keywords
- gamma
- compounds useful
- ror
- inhibiting ror
- inhibiting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/20—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Η παρούσα εφεύρεση παρέχει νέους αναστολείς του ROR γάμμα-t και φαρμακευτικές συνθέσεις αυτών, τύπος (Α).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762466117P | 2017-03-02 | 2017-03-02 | |
| PCT/US2018/019920 WO2018160550A1 (en) | 2017-03-02 | 2018-02-27 | Compounds useful for inhibiting ror-gamma-t |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124177T1 true CY1124177T1 (el) | 2022-05-27 |
Family
ID=61622740
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100455T CY1124177T1 (el) | 2017-03-02 | 2021-05-26 | Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τ |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US11008336B2 (el) |
| EP (1) | EP3589638B1 (el) |
| JP (1) | JP6766273B2 (el) |
| CN (1) | CN110337440B (el) |
| CY (1) | CY1124177T1 (el) |
| DK (1) | DK3589638T3 (el) |
| ES (1) | ES2871911T3 (el) |
| HR (1) | HRP20210898T1 (el) |
| HU (1) | HUE054483T2 (el) |
| LT (1) | LT3589638T (el) |
| PL (1) | PL3589638T3 (el) |
| PT (1) | PT3589638T (el) |
| RS (1) | RS61788B1 (el) |
| SI (1) | SI3589638T1 (el) |
| WO (1) | WO2018160550A1 (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022122740A1 (en) | 2020-12-07 | 2022-06-16 | Diaccurate | Ror-gamma inhibitors for the treatment of ror-gamma-dependent cancer |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA05000729A (es) * | 2002-07-17 | 2005-04-08 | Warner Lambert Co | Combinacion de un inhibidor alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib. |
| UA107943C2 (en) | 2009-11-16 | 2015-03-10 | Lilly Co Eli | Compounds of spiropiperidines as antagonists of the orl-1 receptors |
| SI2501704T1 (sl) | 2009-11-16 | 2013-11-29 | Eli Lilly Company | Spojine spiropiperidina kot antagonisti oral-1 receptorja |
| TWI582096B (zh) | 2011-12-06 | 2017-05-11 | 美國禮來大藥廠 | 用於酒精依賴及濫用處理之４',５'－二氫螺［哌啶－４,７'－噻吩并[２，３－c]哌喃］化合物 |
| WO2014179564A1 (en) | 2013-05-01 | 2014-11-06 | Vitae Pharmaceuticals, Inc. | Thiazalopyrrolidine inhibitors of ror-gamma |
| JP6192836B2 (ja) * | 2013-07-30 | 2017-09-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｒｏｒｃモジュレーターとしてのアザインドール化合物 |
| WO2015101928A1 (en) * | 2013-12-31 | 2015-07-09 | Aurigene Discovery Technologies Limited | Fused thiophene and thiazole derivatives as ror gamma modulators |
| MX2016009621A (es) * | 2014-01-24 | 2016-11-17 | Abbvie Inc | Derivados de fur0-3-carboxamida y metodos de uso. |
| AR105821A1 (es) | 2015-09-09 | 2017-11-15 | Lilly Co Eli | COMPUESTOS ÚTILES PARA INHIBIR ROR-g-T |
| PT3589637T (pt) * | 2017-03-02 | 2021-06-02 | Lilly Co Eli | Compostos úteis para inibir ror-gamma-t |
-
2018
- 2018-02-27 CN CN201880014926.2A patent/CN110337440B/zh active Active
- 2018-02-27 HU HUE18710653A patent/HUE054483T2/hu unknown
- 2018-02-27 JP JP2019547499A patent/JP6766273B2/ja active Active
- 2018-02-27 RS RS20210549A patent/RS61788B1/sr unknown
- 2018-02-27 LT LTEP18710653.9T patent/LT3589638T/lt unknown
- 2018-02-27 PL PL18710653T patent/PL3589638T3/pl unknown
- 2018-02-27 PT PT187106539T patent/PT3589638T/pt unknown
- 2018-02-27 ES ES18710653T patent/ES2871911T3/es active Active
- 2018-02-27 US US16/482,577 patent/US11008336B2/en active Active
- 2018-02-27 SI SI201830267T patent/SI3589638T1/sl unknown
- 2018-02-27 DK DK18710653.9T patent/DK3589638T3/da active
- 2018-02-27 EP EP18710653.9A patent/EP3589638B1/en active Active
- 2018-02-27 WO PCT/US2018/019920 patent/WO2018160550A1/en unknown
-
2021
- 2021-05-26 CY CY20211100455T patent/CY1124177T1/el unknown
- 2021-06-07 HR HRP20210898TT patent/HRP20210898T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE054483T2 (hu) | 2021-09-28 |
| US11008336B2 (en) | 2021-05-18 |
| SI3589638T1 (sl) | 2021-08-31 |
| ES2871911T3 (es) | 2021-11-02 |
| US20200048279A1 (en) | 2020-02-13 |
| HRP20210898T1 (hr) | 2021-08-20 |
| JP2020509049A (ja) | 2020-03-26 |
| CN110337440B (zh) | 2021-08-03 |
| PT3589638T (pt) | 2021-05-27 |
| RS61788B1 (sr) | 2021-06-30 |
| CN110337440A (zh) | 2019-10-15 |
| EP3589638A1 (en) | 2020-01-08 |
| JP6766273B2 (ja) | 2020-10-07 |
| PL3589638T3 (pl) | 2021-09-27 |
| DK3589638T3 (da) | 2021-06-07 |
| LT3589638T (lt) | 2021-06-10 |
| WO2018160550A1 (en) | 2018-09-07 |
| EP3589638B1 (en) | 2021-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021024224A2 (pt) | Inibidores de tead e usos dos mesmos | |
| CY1120988T1 (el) | Παρεμποδιστες διαρυλ κινασης | |
| MD3710446T2 (ro) | Compuși utili pentru inhibarea CDK7 | |
| CL2022000448A1 (es) | Autoinyector (divisional solicitud no. 201903061) | |
| CY1124215T1 (el) | Μκ2 αναστολεις και χρησεις αυτων | |
| CL2016003422A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
| CY1122287T1 (el) | Ενωσεις χρησιμες για την αναστολη toy ror-γαμμα-τ | |
| CL2016003423A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
| CY1124258T1 (el) | ΕΝΩΣΕΙΣ ΧΡΗΣΙΜΕΣ ΓΙΑ ΑΝΑΣΤΟΛΗ ROR-γ-t | |
| MX2019014104A (es) | Compuesto novedoso de bifenilo o sal del mismo. | |
| CY1124338T1 (el) | Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων | |
| BR112018073100A2 (pt) | material luminescente | |
| BR112017023225A2 (pt) | inibidor de proteína cinase | |
| MX2019010643A (es) | Formas y composiciones de un inhibidor de proteina cinasa 2 activada por la proteina cinasa activada por mitogeno (mk2). | |
| CY1121171T1 (el) | Πυρογλουταμικη βορτιοξετινη | |
| BR112018074985A2 (pt) | composições antibacterianas | |
| UY37560A (es) | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta | |
| CY1122381T1 (el) | Παραγωγα ιμιδαζοπυριδαζινης ως αναστολεις pi3kbhta | |
| PH12019500121A1 (en) | Combination of a bcl-2 inhibitor and a mcl-1 inhibitor, uses and pharmaceutical compositions thereof | |
| CY1124177T1 (el) | Ενωσεις χρησιμες για την αναστολη του ror-γαμμα-τ | |
| EA201990313A1 (ru) | Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека | |
| NO20161136A1 (en) | Compounds and compositions for biofilm prevention | |
| CL2019001859A1 (es) | Combinación de un inhibidor de mcl-1 y un compuesto taxano, usos y composiciones farmacéuticas de ésta. | |
| EA201991623A1 (ru) | Комбинация mcl-1 ингибитора и таксанового соединения, их применения и фармацевтические композиции | |
| EA202090930A1 (ru) | Соединения, пригодные для ингибирования cdk7 |